A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium

被引：0
|
作者：
Nong Xu
Xiao Chen Zhang
Jian Ping Xiong
Wei Jia Fang
Lan Fang Yu
Jiong Qian
Ling Zhang
机构：
[1] Zhejiang University,Department of Medical Oncology, The First Affiliated Hospital, School of Medicine
[2] Nanchang University,Department of Oncology, The First Affiliated Hospital
来源：
BMC Cancer | / 7卷
关键词：
Bone Metastasis; Carboplatin; Transitional Cell Carcinoma; Overall Response Rate; Eastern Cooperative Oncology Group Performance Status;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium
    Xu, Nong
    Zhang, Xiao Chen
    Xiong, Jian Ping
    Fang, Wei Jia
    Yu, Lan Fang
    Qian, Jiong
    Zhang, Ling
    [J]. BMC CANCER, 2007, 7 (1)
  • [2] A phase II trial of pemetrexed plus gemcitabine in locally advanced and/or metastatic transitional cell carcinoma of the urothelium
    von der Maase, H.
    Lehmann, J.
    Gravis, G.
    Joensuu, H.
    Geertsen, P. F.
    Gough, J.
    Chen, G.
    Kania, M.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 (10) : 1533 - 1538
  • [3] Phase II trial of gemcitabine plus carboplatin for urothelial transitional cell carcinoma (UTCC) in advanced or metastatic stage
    Santoro, A
    Santoro, M
    Maiorino, L
    Forestieri, V
    Forestieri, P
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 169 - 169
  • [4] Gemcitabine plus cisplatin versus gemcitabine plus carboplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium:: Results of a randomized phase 2 trial
    Dogliotti, Luigi
    Carteni, Giacomo
    Siena, Salvatore
    Bertetto, Oscar
    Martoni, Andrea
    Bono, Aldo
    Amadori, Dino
    Onat, Haluk
    Marini, Luca
    [J]. EUROPEAN UROLOGY, 2007, 52 (01) : 134 - 141
  • [5] Gemcitabine and carboplatin in the treatment of transitional cell carcinoma of the urothelium
    Hudson, E.
    Lester, J. F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] Paclitaxel, carboplatin, and gemcitabine in the treatment of patients with advanced transitional cell carcinoma of the urothelium - A phase II trial of the Minnie Pearl Cancer Research Network
    Hainsworth, JD
    Meluch, AA
    Litchy, S
    Schnell, FM
    Bearden, JD
    Yost, K
    Greco, FA
    [J]. CANCER, 2005, 103 (11) : 2298 - 2303
  • [7] A phase II trial of pemetrexed plus gemcitabine as first-line treatment for locally advanced or metastatic transitional cell carcinoma of the urothelium
    von der Maase, H
    Lehmann, J
    Gravis, G
    Joensuu, H
    Bihn, B
    Geertsen, P
    Gough, J
    Chen, ZJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 400S - 400S
  • [8] Gemcitabine in the treatment of advanced transitional cell carcinoma of the urothelium
    Bellmunt, J.
    Albiol, S.
    Ramirez de Olano, A.
    Pujadas, J.
    Maroto, P.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : V113 - V117
  • [9] Gemcitabine plus cisplatin for advanced transitional cell carcinoma of the urinary tract: A phase II multicenter trial
    Lorusso, V
    Manzione, L
    De Vita, F
    Antimi, M
    Selvaggi, FP
    De Lena, M
    [J]. JOURNAL OF UROLOGY, 2000, 164 (01): : 53 - 56
  • [10] Weekly, paclitaxel plus carboplatin in patients with metastatic transitional cell carcinoma of the urothelium who failed MVAC: Phase II trial
    Kouno, T.
    Ando, M.
    Yonemori, K.
    Matsumoto, K.
    Komiyama, M.
    Okajima, E.
    Matsuoka, N.
    Fujimoto, H.
    Fujiwara, Y.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 246 - 247
12345